US 11370803
Heteroaryl plasma kallikrein inhibitors
granted A61PA61P29/02
Quick answer
US patent 11370803 (Heteroaryl plasma kallikrein inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P29/02